AngioDynamics, Inc. (ANGO)
12.36
+0.34
(+2.87%)
USD |
NASDAQ |
Oct 23, 16:00
12.37
0.00 (0.00%)
Pre-Market: 20:00
AngioDynamics Market Cap : 524.58M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 524.58M |
| October 22, 2026 | 509.94M |
| October 21, 2026 | 504.43M |
| October 20, 2026 | 501.03M |
| October 19, 2026 | 483.21M |
| October 16, 2026 | 476.85M |
| October 15, 2026 | 491.27M |
| October 14, 2026 | 468.79M |
| October 13, 2026 | 462.43M |
| October 12, 2026 | 483.64M |
| October 09, 2026 | 488.73M |
| October 08, 2026 | 476.43M |
| October 07, 2026 | 602.00M |
| October 06, 2026 | 611.76M |
| October 05, 2026 | 659.28M |
| October 02, 2026 | 630.09M |
| October 01, 2026 | 630.51M |
| September 30, 2026 | 641.35M |
| September 29, 2026 | 650.53M |
| September 28, 2026 | 648.02M |
| September 25, 2026 | 645.94M |
| September 24, 2026 | 637.18M |
| September 23, 2026 | 646.77M |
| September 22, 2026 | 653.45M |
| September 21, 2026 | 643.02M |
| Date | Value |
|---|---|
| September 18, 2026 | 643.85M |
| September 17, 2026 | 640.94M |
| September 16, 2026 | 644.69M |
| September 15, 2026 | 653.86M |
| September 14, 2026 | 646.77M |
| September 11, 2026 | 636.77M |
| September 10, 2026 | 635.51M |
| September 09, 2026 | 638.85M |
| September 08, 2026 | 634.68M |
| September 04, 2026 | 633.85M |
| September 03, 2026 | 645.11M |
| September 02, 2026 | 651.36M |
| September 01, 2026 | 661.37M |
| August 31, 2026 | 672.63M |
| August 28, 2026 | 660.95M |
| August 27, 2026 | 658.03M |
| August 26, 2026 | 654.28M |
| August 25, 2026 | 665.12M |
| August 24, 2026 | 657.62M |
| August 21, 2026 | 656.78M |
| August 20, 2026 | 659.70M |
| August 19, 2026 | 670.13M |
| August 18, 2026 | 659.70M |
| August 17, 2026 | 653.45M |
| August 14, 2026 | 660.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 66.10B |
| Globus Medical, Inc. | 10.93B |
| Penumbra, Inc. | 12.78B |
| Abbott Laboratories | 179.44B |
| Alphatec Holdings, Inc. | 1.696B |
Market Cap Related Metrics
| PS Ratio | 1.585 |
| PEG Ratio | -17.51 |
| Price to Book Value | 3.199 |
| Price | 12.36 |
| Earnings Yield | -6.39% |
| PEGY Ratio | -17.51 |